These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37745712)

  • 1. Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance.
    Ding W; Ruan G; Lin Y; Zhu J; Li Z; Ye D
    Front Endocrinol (Lausanne); 2023; 14():1235006. PubMed ID: 37745712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
    Sudoko CK; Jenks CM; Bauer AJ; Isaza A; Mostoufi-Moab S; Surrey LF; Bhatti TR; Franco A; Adzick NS; Kazahaya K
    JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):943-950. PubMed ID: 34554217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis.
    Qian B; Hu L; Zhang S; Zhu J; Mei L; Huang T; Qu X
    Front Endocrinol (Lausanne); 2022; 13():944758. PubMed ID: 35992148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Cervical Lymph Node Metastasis Increase the Risk of Distant Metastasis in Papillary Thyroid Carcinoma?
    Wang W; Ding Y; Jiang W; Li X
    Front Endocrinol (Lausanne); 2022; 13():917794. PubMed ID: 35813656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival benefit of active surveillance for papillary thyroid carcinoma: a propensity score matching analysis based on SEER database.
    Bi J; Lyu PF; Wang Y; Zhang H
    Front Oncol; 2023; 13():1185650. PubMed ID: 37361590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
    Sakai T; Sugitani I; Ebina A; Fukuoka O; Toda K; Mitani H; Yamada K
    Thyroid; 2019 Jan; 29(1):59-63. PubMed ID: 30560718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors analyses for lateral neck lymph node metastasis in papillary thyroid carcinoma].
    Qi ZJ; Liu LF; Cheng L; Han X; Wang T; Li F; Lu C; Zhang AB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):603-606. PubMed ID: 31327195
    [No Abstract]   [Full Text] [Related]  

  • 9. Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients.
    Song RY; Kim HS; Kang KH
    World J Surg Oncol; 2022 May; 20(1):170. PubMed ID: 35643530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Dependent Clinicopathological Characteristics of Patients with T1b Papillary Thyroid Carcinoma: Implications for the Possibility of Active Surveillance.
    Won HR; Jeon E; Heo DB; Chang JW; Shong M; Kim JR; Ko H; Kang YE; Yi HS; Lee JH; Joung KH; Kim JM; Lee Y; Kim SW; Jeong YJ; Ji YB; Tae K; Koo BS;
    Ann Surg Oncol; 2023 Apr; 30(4):2246-2253. PubMed ID: 36581723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active Surveillance for Small Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis.
    Cho SJ; Suh CH; Baek JH; Chung SR; Choi YJ; Chung KW; Shong YK; Lee JH
    Thyroid; 2019 Oct; 29(10):1399-1408. PubMed ID: 31368412
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
    Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy.
    Papachristos A; Do K; Tsang VH; Sywak M; Gill AJ; Sidhu S; Clifton-Bligh RJ; Glover A; Gild ML
    Thyroid; 2022 Sep; 32(9):1086-1093. PubMed ID: 35703333
    [No Abstract]   [Full Text] [Related]  

  • 14. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
    J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
    Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
    J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.
    Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim YN; Kim H; Ahn HS; Kim K; Kim SW; Chung JH
    Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
    Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
    Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
    [No Abstract]   [Full Text] [Related]  

  • 18. Nomograms based on preoperative multimodal ultrasound of papillary thyroid carcinoma for predicting central lymph node metastasis.
    Dai Q; Liu D; Tao Y; Ding C; Li S; Zhao C; Wang Z; Tao Y; Tian J; Leng X
    Eur Radiol; 2022 Jul; 32(7):4596-4608. PubMed ID: 35226156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
    Kim M; Kim HK; Kim HI; Kim EH; Jeon MJ; Yi HS; Kim ES; Kim H; Kim TH; Kim BH; Kim TY; Kang HC; Kim WB; Chung JH; Shong YK; Kim SW; Kim WG
    Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?
    Wu Z; Han L; Li W; Wang W; Chen L; Yao Y; Wang Y
    Cancer Med; 2021 Mar; 10(5):1614-1622. PubMed ID: 33512778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.